Angiography Equipment

Global Angiography Equipment Market to Reach US$17.6 Billion by 2030

The global market for Angiography Equipment estimated at US$13.2 Billion in the year 2024, is expected to reach US$17.6 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Angiography Systems, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Catheters segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 9.1% CAGR

The Angiography Equipment market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Angiography Equipment Market – Key Trends & Drivers Summarized

Why Is Angiography Equipment Central to Precision Cardiovascular and Vascular Diagnosis?
Angiography equipment plays a pivotal role in modern medical diagnostics by providing high-resolution imaging of blood vessels, enabling the detection and assessment of cardiovascular, cerebrovascular, and peripheral vascular diseases. These systems guide interventional procedures by allowing clinicians to visualize arterial blockages, aneurysms, stenosis, and malformations in real time. With heart disease and stroke remaining leading causes of mortality globally, angiography serves as a frontline tool in reducing diagnostic uncertainty and improving procedural outcomes.

By injecting contrast agents and capturing dynamic X-ray or fluoroscopic images, angiography systems deliver clear, contrast-enhanced views of vascular structures in motion. This allows clinicians to plan interventions such as angioplasty, stent placement, or thrombectomy with greater accuracy and confidence. Equipment ranges from traditional fixed cath labs to advanced hybrid operating rooms and portable C-arm systems, catering to a spectrum of clinical needs from emergency diagnostics to complex surgical navigation.

The importance of angiography is amplified in high-risk patient populations, including those with diabetes, hypertension, or chronic kidney disease, where early vascular assessment can be life-saving. Its integration with real-time monitoring and image-guided therapy makes it indispensable in both diagnostic cardiology and minimally invasive surgical disciplines. As healthcare systems move toward precision medicine and outcome-based care, angiography’s ability to support targeted treatment planning continues to make it a critical asset in interventional medicine.

How Are Imaging Enhancements and Workflow Innovations Transforming Angiography Platforms?
Technological advancements are redefining the capabilities of angiography equipment, with innovations in detector design, image processing algorithms, and dose management significantly enhancing diagnostic performance. Flat-panel detectors with higher spatial and contrast resolution allow for sharper vascular imaging while reducing radiation exposure to patients and operators. Digital subtraction angiography (DSA) techniques are now complemented by advanced image fusion, motion correction, and AI-assisted reconstruction tools to deliver clearer, artifact-free images even in complex vascular anatomies.

Workflow optimization has become a focal point in angiography suite development. Modern systems are equipped with automated positioning, real-time navigation overlays, and integrated control consoles that streamline procedural flow and reduce procedural time. User-centric interfaces, remote diagnostics, and system interoperability with hospital IT infrastructure enable faster case turnover and minimize downtime—crucial in high-volume centers and emergency departments. Moreover, the rise of all-in-one interventional platforms that combine angiography with 3D imaging and surgical navigation is transforming procedural planning and execution.

Radiation safety and contrast media optimization are also being prioritized through features such as dose tracking, pulsed fluoroscopy, and low-dose imaging protocols. Advanced injector integration and real-time perfusion assessment tools further reduce contrast volume and procedure-related risks. These enhancements are driving adoption in both public and private healthcare settings, especially where regulatory pressure and patient safety standards are high. As imaging systems evolve toward lower-risk, higher-precision outputs, the demand for next-gen angiography solutions is poised to rise across both developed and emerging economies.

Which Clinical Domains and Global Markets Are Catalyzing Demand for Angiography Equipment?
Cardiology remains the dominant clinical domain for angiography equipment, particularly in the diagnosis and treatment of coronary artery disease (CAD), structural heart conditions, and congenital anomalies. The growing burden of cardiovascular disease—exacerbated by aging populations and lifestyle factors—is prompting hospitals and cardiac centers to invest in advanced cath labs and hybrid operating rooms. Interventional radiology and neurology are also expanding end-user segments, where angiography supports image-guided procedures for stroke management, aneurysm coiling, and tumor embolization.

Demand is further growing in peripheral vascular interventions, oncology, and trauma care, where angiographic systems support procedures like endovascular aneurysm repair (EVAR), uterine artery embolization, and limb salvage surgery. In oncology, angiography is used to guide targeted therapies such as transarterial chemoembolization (TACE) and selective internal radiation therapy (SIRT). The expansion of interventional oncology and personalized care models is increasing the clinical value of angiographic platforms beyond traditional cardiovascular use cases.

Geographically, North America and Europe lead in installed base and technology adoption, backed by established interventional infrastructure, reimbursement frameworks, and a high concentration of cardiovascular care centers. However, Asia-Pacific is witnessing the fastest growth, driven by increasing healthcare expenditure, rising cardiovascular disease prevalence, and investments in medical imaging modernization in China, India, and Southeast Asia. Latin America, the Middle East, and Africa are gradually increasing adoption through public health infrastructure expansion, foreign direct investments, and growing private sector involvement in tertiary care.

How Are Reimbursement Trends, Clinical Integration, and Innovation Cycles Influencing Market Development?
Reimbursement policies are playing a critical role in shaping angiography equipment adoption, particularly in markets with public healthcare systems. Procedural coding, bundled payments, and value-based reimbursement models are incentivizing hospitals to adopt systems that reduce procedure time, improve diagnostic yield, and minimize complications. This shift is prompting OEMs to develop angiography platforms that support multimodal imaging, enable outcome tracking, and integrate with electronic health records for documentation and analytics.

Clinical integration is also a key growth lever. As angiography systems are increasingly used in hybrid ORs and multidisciplinary workflows, equipment is being designed for compatibility with surgical navigation, robotic systems, and AI-powered clinical decision support tools. Seamless integration with CT, MRI, and ultrasound data is enhancing preoperative planning and intraoperative guidance, creating a unified imaging ecosystem. Such interoperability is especially critical in high-acuity cases requiring dynamic decision-making and cross-specialty collaboration.

Innovation cycles are accelerating due to rapid advances in 3D imaging, cone-beam CT, and artificial intelligence. AI-driven automation is improving lesion detection, procedural planning, and post-procedure assessment, while 3D roadmapping and virtual stent placement are enabling higher precision in device deployment. Meanwhile, mobile and compact angiography systems are gaining traction in point-of-care and resource-constrained settings, offering flexibility without compromising image quality. These developments are expanding the market from high-end cath labs to ambulatory centers and secondary care facilities.

What Are the Factors Driving Growth in the Angiography Equipment Market?
The angiography equipment market is expanding steadily due to rising cardiovascular and neurovascular disease incidence, increasing procedural volumes in interventional radiology, and the global push toward minimally invasive, image-guided therapies. The convergence of imaging precision, workflow efficiency, and multi-specialty application potential is reinforcing the relevance of angiography platforms across tertiary and community care settings. Key growth drivers include demand for hybrid ORs, increased adoption in emerging economies, and the need for radiation- and contrast-efficient technologies.

As healthcare delivery shifts toward outpatient, personalized, and value-based models, angiography equipment is evolving from a single-function diagnostic tool into a central enabler of integrated care pathways. The ability to combine real-time imaging with therapeutic interventions, supported by data-driven insights and advanced automation, is driving sustained capital investment from hospitals, health systems, and private clinics. Ongoing innovation and digitization are also reducing total cost of ownership and improving system lifecycle value for buyers.

Looking ahead, the trajectory of angiography equipment will be shaped by how well vendors address the imperatives of clinical versatility, cost-efficiency, and operational scalability. As interventional care becomes more technology-dependent and image-centric, could angiography systems redefine the standard of precision across the global continuum of care?

SCOPE OF STUDY:

The report analyzes the Angiography Equipment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Angiography Systems, Catheters, Guidewire, Balloons, Contrast Media, Vascular Closure Devices, Other Product Types); Technology (X-Ray, MRI, CT); Procedure (Coronary, Endovascular, Neurovascular); Application (Diagnostic, Therapeutic); End-User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Diagnostic Centers, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AngioDynamics Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Bracco Imaging S.p.A.
• Canon Medical Systems Corporation
• Cardinal Health Inc.
• Cook Medical LLC
• Cordis Corporation
• Curatia Medical Inc.
• Fujifilm Holdings Corporation
• GE Healthcare
• Guerbet Group
• Hitachi Medical Systems
• Hologic Inc.
• Koninklijke Philips N.V.
• Lantheus Medical Imaging, Inc.
• Lohmann & Rauscher GmbH & Co. KG
• Medtronic plc
• MicroPort Scientific Corporation

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.